FAQs ABOUT CITIBRAL 250MG INJECTION
What is CITIBRAL 250MG INJECTION used for?
GBNKEYWORD] is used to treat disturbances of consciousness that occurs due to head injuries, brain operation, and acute cerebral infraction in affected individuals. It is also used to treat Alzheimer’s disease and memory loss due to Parkinson’s disease which is also indicated for use in the recovery phase of cerebral infarction (poor blood supply to the brain) in affected individuals.
What are the side effects of CITIBRAL 250MG INJECTION?
The most common side effects of receiving CITIBRAL 250MG INJECTION are diarrhoea, nausea, stomach pain, rash, insomnia (sleeplessness), and/or occurrence/intensification of numbness. Consult your doctor if any of these symptoms worsens.
How CITIBRAL 250MG INJECTION works?
CITIBRAL 250MG INJECTION works by increasing the synthesis of phosphatidylcholine (chemical that produces acetylcholine, responsible for memory and other bodily functions) which leads to improved cerebral function and cognitive function in Alzheimer’s disease and Parkinson’s disease. It also works by repairing neuronal membranes and damaged cholinergic neurons via potentiation of acetylcholine production and reduction of free fatty acid accumulation at stroke-induced nerve damage site which results in the prevention neuronal cell death thus helping in the recovery phase of cerebral infarction in affected individuals.
How CITIBRAL 250MG INJECTION is administered?
CITIBRAL 250MG INJECTION will be given to you only by a doctor or a nurse into a vein as an intravenous infusion or into a muscle as an intramuscular injection. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
What happens if CITIBRAL 250MG INJECTION is received more than its required dosage?
CITIBRAL 250MG INJECTION will be administered to you only by a doctor or a nurse in a hospital, and so it is unlikely to receive an overdose. However, consult your doctor or nurse if you experience any unusual symptoms.